Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03156465 · ClinicalTrials.gov registry record · NA
Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants
A NA study of Child and Hearing Loss, Bilateral, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 2
- Study locations
NCT03156465: Completed NA study of Child and Hearing Loss, Bilateral, sponsored by University of Iowa.
NCT03156465 is a NA study of Child and Hearing Loss, Bilateral that has completed, run by University of Iowa. The registered enrollment target is 11 participants, below the 270-participant average among 8 other Child trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03156465, a NA study of Child and Hearing Loss, Bilateral, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this feasibility study is to evaluate whether implantation of one Nucleus L24 electrode array and one FDA approved standard-length device in the contralateral ear can provide useful binaural hearing in pediatric subjects who have bilateral severe to profound hearing loss, meeting the criteria for cochlear implantation. Unlike a conventional cochlear implant, the Nucleus L24 is expected to preserve the regions of the cochlear partition that are apical to the electrode, thus leaving them available for possible future advances in the field of otolaryngology and hearing devices, such as mammalian hair cell regeneration techniques or improved implantable hearing devices. Whether or not this group of children will be able to take advantage of future hair cell regeneration strategies is yet to be determined and will have to wait for future development. At this time there are no accurate imaging strategies available to identify preservation of the scala media. Ultra thin micro CT scanning is in development, however the level of radiation delivery to the subject is too great to be considered for clinical use. When imaging strategies become available to determine cellular structure of the inner ear, they will be applied to this group of subjects. The Nucleus L24 array stimulates the basal turn of the cochlea, in an attempt to preserve the middle and apical regions of the scala media.
Primary Outcome
Parent questionnaire that consists of ten questions regarding a young infant or toddler's auditory behavior, e.g. "Does the child spontaneously respond to his/her name in quiet with auditory cues?" Each question is scored on a five point scale: 0=never, 1=rarely, 2=occasionally, 3=frequently, and 4=always. The aim of this tool is to assess the benefit of the child's personal amplification device(s). This questionnaire is generally used during the cochlear implant work-up to assess hearing aid be
Conditions Studied
Interventions
- DEVICE Hybrid L24
Study Locations (2)
Iowa
- University of Iowa - Iowa City
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-09-15 |
| Est. Completion | 2022-11-03 |
| Phase | NA |
What the finished NCT03156465 record still lists
NCT03156465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 270-participant average among 8 other Child trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Child appearing as the primary indexed condition, and to 1 intervention - of which Hybrid L24 is the first listed.
NCT03156465 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT03156465 about?
NCT03156465 is a clinical study titled "Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants". The purpose of this feasibility study is to evaluate whether implantation of one Nucleus L24 electrode array and one FDA approved standard-length device in the contralateral ear can provide useful binaural hearing in pediatric subjects who have bilateral severe to profound hearing loss, meeting the ...
What is the current status of trial NCT03156465?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2011-09-15. Estimated completion is 2022-11-03.
What conditions does trial NCT03156465 study?
This clinical trial studies the following conditions: Child, Hearing Loss, Bilateral, Implants, Cochlear.
What interventions are being tested in trial NCT03156465?
The interventions under investigation include: Hybrid L24 (DEVICE).
Who is sponsoring clinical trial NCT03156465?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03156465 being conducted?
This trial has 2 study locations across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03156465's enrollment target sits among peer trials
11 9th of 8 the lowest of 8 other Child trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
RECRUITING · NA
-
Guardians Receiving Information Through Navigators
RECRUITING · NA
-
Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair
COMPLETED · NA
-
Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study
COMPLETED · NA
-
The Childhood Health and Asthma Management Program
COMPLETED · NA
-
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI